Resitu: minimally invasive surgical technology

The team revolutionising cancer management

The Resitu Medical core team has more than 100 years of combined experience in life science and the medical device sector.

To get in contact with Resitu Medical: Visit the contact page.

CEO
Stefan Sowa, MSc, MBA 

Stefan Sowa has worked in the Life Science industry since 1984. Twenty of these years has been devoted to Medical Devices, including ten years as production manager and six years as CEO in development, manufacturing and sales of surgical implants. Stefan has held positions as business development consultant, coach and board member.

Chief Commercial Officer
Therese Sundell, MSc

Therese Sundell has over 20 years of experience of stategic and tactical marketing in the life science industry on a global level. She has built and headed marketing teams, developed new corporate identities and websites, conducted market research and organised and executed marketing activities. 

COO
Heather Marshall-Heyman, MSc, PhD

Heather Marshall-Heyman is an experienced project and programme manager with background in life sciences. For the past 15 years, she has been working with strategic development of innovations within SMEs in the life science sector. She is an expert in strategic project and partnership development, science writing, innovation funding and international project collaboration.

Chief Regulatory Officer, Partner
Åsa Runnäs, MSc

Åsa Runnäs has 15+ years' experience of work within the medical device and in-vitro diagnostic field, where Åsa's expertise is within Regulatory Affairs and Quality Assurance. She founded Clarvin AB / Inc. and has held several manager roles in medical device companies.

Chief Medical Officer, Partner
Elisabeth Liljensten, DDS, PhD

Elisabeth Liljensten has over 20 years of experience in clinical and preclinical development in medical devices. She founded Devicia AB/Inc and has held several director roles in Swedish and US medical device companies. Elisabeth has been chair of MEDEA, a Swedish branch organization for consultants in medical technology. She is an expert in ISO standards, governing the conduct of clinical investigations.

Chief Technology Officer, Partner
Per Egnelöv

Per Egnelöv has over 30 years of experience in the medical device sector with emphasis on product development of Class 2 and 3 products. Per is a skilled medical device inventor and developer. He has long experience and technical expertise in development of prototypes and final construction of medical technical instruments.

Board Members

Pär Nordström, M Sc Chairman of the Board

Solid Venture Capital and board experience. Broad and extensive experience within international sales, marketing, management, advanced technology and medicine. Global business experiences. Experience from therapy within Cardiology, Neurosurgery, Radiotherapy and Oncology.

Per Hedén, MD, PhD, Inventor, founder. Ass prof. plastic surgery KI, co-founder Akademikliniken

Dr. Per Hedén is an Associate Professor of Plastic Surgery at Karolinska Institute in Stockholm. Sweden. He was the pioneer in establishing microsurgical procedures in the Stockholm region in the beginning of the 1980's and still has a profound interest in reconstructive surgery and a special interest in facial paralysis reanimations. Dr Hedén is the Founder of Akademikliniken, Europe’s largest private hospital exclusively for plastic surgery.

Håkan Sjunnesson, M Sc, founder

Investor, Chair of several growth companies including Paradox Interactive AB, Coolstuff AB, Qvalia Group AB, Emerse AB and Aktivbo Group AB. Member of the board in NuvoAir AB, Novoaim AB and Dalex AB. Previous assignments include Investment Manager Spiltan Invest AB, Managing Partner Nordic Countries Monitor Group, Vice President & Country Manager Gemini Consulting.

Gustav Notander, M Sc, ALMI Invest Stockholm

Gustav has a MSc.Eng. in Biotechnology from KTH Royal Institute of Technology in Stockholm. He is currently working as Investment Manager at Almi Invest Stockholm, and in addition to Resitu, is a member of the board in Developeration AB, and Medituner AB. 

He has previously worked 15+ years as a business development coach and technology transfer manager at KTH Innovation, and as IP Manager at KTH Holding AB.

Claes Post, MSc, PhD Pharmacy, STOAF Invest Stockholm 

Other Current assignments: General Partner STOAF III SCITECH, member of the Board of Vakona AB, Developeration AB, and STOAF III Venture Partners AB. Previous Adjunct Professor Uppsala University, Lund University and Karolinska Institute. Previous assignments include Vice President and Senior Vice President positions at Astra and Pharmacia, CEO and Board positions at many Life Science start-up companies, including Dicot AB, AroCell AB, and IDL Biotech AB. Also partner at Danske Life Science, venture partner HealthCap and Nordic Biotech, and Investment Manager at ALMI Invest. 

Resitu

Resitu Medical AB
Rapsgatan 7B
Uppsala, Sweden

info@resitumedical.com

Resitu Medical AB is a Swedish Medical Device company founded in 2019. The company is developing instruments enabling safe removal of intact tissues by a revolutionary technology. The solution has the potential to create a paradigm shift in the management of breast cancer. The portfolio of instruments will speed up the process of cancer management using a minimally invasive approach and facilitating the way radiologists and surgeons work.

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively.